Standardization of a single-cell assay for sensitive detection of multidrug resistance protein expression in normal and malignant cells in archival clinical samples

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 3, 1997, Pages 297-306

  Chan, Helen S L ^a,e   Grogan, Thomas M ^f   Haddad, George ^f   Hipfner, David R ^d   Deeley, Roger G ^c   Cole, Susan P C ^b  

^a Institut national du cancer du Canada   (Canada)

^b Ontario Cancer Treatm Res Found   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d Medical Research Council of Canada   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031239744     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90025-1     Document Type: Article

References (42)

1. Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258:1650-4.
2. Gros P, Ben Neriah YB, Croop JM, Housman DE. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 1986;323:728-31.
3. Dalton WS, Grogan TM, Meltzer PS, et al. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 1989;7:415-24.
4. Bourhis J, Bénard J, Hartmann O, Boccon-Gibod L, Lemerle J, Riou G. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst 1989;81: 1401-5.
5. Chan HSL, Thorner PS, Haddad G, Ling V. Immunohisto-chemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990;8:689-704.
6. Chan HSL, Haddad G, Thorner PS, et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991;325:1608-14.
7. Campos L, Guyotat D, Archimbaud E, et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992;79:473-6.
8. Beck WT. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. J Natl Cancer Inst 1989;81:1683-5.
9. r 110,000 vesicular protein in non-P-glycoproteinmediated multidrug resistance. Cancer Res 1993;53:1475-9.
10. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994;54:4313-20.
11. List AF, Spier C, Greer J, et al. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 1993;11:1652-60.
12. Sikic BI. Modulation of multidrug resistance: at the threshold. J Clin Oncol 1993;11:1629-35.
13. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994;54:357-61.
14. Kuss BJ, Deeley RG, Cole SPC, et al. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet 1994;343:1531-4.
15. Cole SPC, Sparks KE, Fraser K, et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994;54:5902-10.
16. Zaman GJ, Versantvoort CHM, Smit JJM, et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993;53:1747-50.
17. Abbaszadegan MR, Futscher BW, Klimecki WT, List A, Dalton WS. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 1994;54:4676-9.
18. Burger H, Nooter K, Zaman GJR, et al. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia 1994;8:990-7.
19. Zhou DC, Hoang-Ngoc L, Delmer A, et al. Expression of resistance genes in acute leukemia. Leuk Lymphoma 1994; 13(suppl 1):27-30.
20. Schneider E, Cowan KH, Bader H, et al. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 1995;85:186-93.
21. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 1994;54:5788-92.
22. Zaman GJ, Flens MJ, van Leusden MR, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 1994; 91:8822-6.
23. Flens MJ, Izquierdo MA, Scheffer GL, et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994;54:4557-63.
24. Nooter K, Westerman AM, Flens MJ, et al. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1995;1:1301-10.
25. Chan HSL, Bradley G, Thorner P, Haddad G, Gallie BL, Ling V. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines. Lab Invest 1988;59:870-5.
26. Haddad G, Thorner PS, Bradley G, Dalton WS, Ling V, Chan HSL. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow. Lab Invest 1994;71:595-603.
27. Hipfner DR, Almquist KC, Stride BD, Deeley RG, Cole SPC. Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of the MRP-specific monoclonal antibody QCRL-1. Cancer Res 1996;56:3307-14.
28. Mirski SE, Gerlach JH, Cole SPC. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res 1987;47:2594-8.
29. Flens MJ, Zaman GJ, van der Valk P, et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 1996; 148:1237-47.
30. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL, Haber M. Expression of the gene for multidrug-resistanceassociated protein and outcome in patients with neuroblastoma. N Engl J Med 1996;334:231-8.
31. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277-87.
32. Cole SPC. Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line. Cancer Chemo Pharmacol 1990;26:250-6.
33. Sternberger LA, Hardy PH Jr, Cuculis JJ, Meyer HG. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 1970;18:315-33.
34. Warnke R, Levy R. Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem 1980;28:771-6.
35. Loe DW, Almquist KC, Deeley RG, Cole SPC. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J Biol Chem 1996;271:9675-82.
36. Loe DW, Almquist KC, Cole SPC, Deeley RG. ATP-dependent 17β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein: inhibition by cholestatic steroids. J Biol Chem 1996;271:9683-9.
37. r 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell. Cancer Res 1995;55:102-10.
38. Coley HM, Amos WB, Twentyman PR, Workman P. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer 1993; 67:1316-23.
39. Krishnamachary N, Center MS. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-Kd membrane bound glycoprotein. Cancer Res 1993;53:3658-61.
40. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 1989;37:159-64.
41. Rao VV, Anthony DC, Piwnica-Worms D. MDR1 genespecific monoclonal antibody C494 cross-reacts with pyruvate carboxylase. Cancer Res 1994;54:1536-41.
42. Chan HSL, Lu Y, Grogan TM, et al. Multidrug resistance protein expression in retinoblastoma correlates with rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res 1997;57:2325-30.